arrow
P

Peđja Kovačević

saint michaels hospital toronto
H指数:12
被引数:870

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Population Pharmacokinetics of Amikacin and Monte Carlo Simulation Study in Critically Ill Septic Patients Undergoing Continuous Renal Replacement Therapy with CytoSorb® or oXiris®

阿米卡星在行连续肾脏替代治疗的危重脓毒症患者中的群体药代动力学及蒙特卡洛模拟研究(使用CytoSorb®或oXiris®)

2026-10-150
OA
Hematological parameter dynamics in critically ill patients treated with oXiris-based CRRT and CytoSorb hemoadsorption: a prospective single-center study

危重症患者接受oXiris基CRRT和CytoSorb血液吸附治疗时的血液学参数动态变化:一项前瞻性单中心研究

2026-05-120
PRE
Consensus statements for the establishment of medical intensive care in low-resource settings: international study using modified Delphi methodology

在资源匮乏的环境中建立医疗重症监护的共识声明: 使用改良Delphi方法的国际研究

2024-10-030
OAAI
Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation-A Step toward Correct Dosing

利奈唑胺的群体药代动力学模型和静脉-静脉体外膜氧合COVID-19相关急性呼吸窘迫综合征患者的目标实现概率-迈向正确剂量的一步

2024-02-080
OAAI
Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 Vaccines

与Moderna,BioNTech,AstraZeneca,sputnik-v,Johnson和Johnson以及Sinopharm的新型冠状病毒肺炎疫苗预防接种后的IgA,IgG和中和抗体反应的比较

2022-06-2139
OAAI